These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 14660822)

  • 1. Water for contrast-induced nephropathy? A thirst for knowledge.
    Pate GE; Webb JG
    J Invasive Cardiol; 2003 Dec; 15(12):703-5. PubMed ID: 14660822
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contrast medica nephropathy. Better understanding of risk markers and follow up needed].
    Sterner G; Hellström M; Lagerqvist B; Aspelin P; Nyman U
    Lakartidningen; 2009 Jun 24-Jul 7; 106(26-27):1737-42. PubMed ID: 19731735
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study.
    Krasuski RA; Beard BM; Geoghagan JD; Thompson CM; Guidera SA
    J Invasive Cardiol; 2003 Dec; 15(12):699-702. PubMed ID: 14660821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-induced nephropathy: does it really exist?
    Buckenham TM
    N Z Med J; 2009 Jul; 122(1299):5-6. PubMed ID: 19684640
    [No Abstract]   [Full Text] [Related]  

  • 5. Using estimated GFR values to identify patients at risk from iodinated contrast induced nephropathy.
    Adair W; Harris K; Entwisle J
    Clin Radiol; 2006 Aug; 61(8):714-5. PubMed ID: 16843758
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.
    Masuda M; Yamada T; Mine T; Morita T; Tamaki S; Tsukamoto Y; Okuda K; Iwasaki Y; Hori M; Fukunami M
    Am J Cardiol; 2007 Sep; 100(5):781-6. PubMed ID: 17719320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
    Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The editor's roundtable: contrast agents and risk for contrast-induced nephropathy.
    Friedewald VE; Goldfarb S; Laskey WK; Vetrovec GW; Roberts WC
    Am J Cardiol; 2011 Jun; 107(12):1848-55. PubMed ID: 21640219
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Using estimated GFR values to identify patients at risk from iodinated contrast-induced nephropathy.
    Dyer JD; Dyer JB
    Clin Radiol; 2007 Mar; 62(3):285; author reply 285. PubMed ID: 17293225
    [No Abstract]   [Full Text] [Related]  

  • 10. Contrast-induced nephropathy: prevention and management of high-risk patients.
    Caixeta A; Nikolsky E; Mehran R
    Indian Heart J; 2008; 60(6):524-31. PubMed ID: 19276490
    [No Abstract]   [Full Text] [Related]  

  • 11. N-acetylcysteine and contrast-induced nephropathy.
    Ritz E
    N Engl J Med; 2006 Oct; 355(14):1499; author reply 1499-500. PubMed ID: 17024738
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug-induced nephropathy].
    Shimizu H; Tanaka A; Matsuo S
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():549-53. PubMed ID: 18074600
    [No Abstract]   [Full Text] [Related]  

  • 13. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines.
    Thomsen HS; Morcos SK
    Br J Radiol; 2003 Aug; 76(908):513-8. PubMed ID: 12893691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast medium administration in the elderly patient: is advancing age an independent risk factor for contrast nephropathy after angiographic procedures?
    Detrenis S; Meschi M; Bertolini L; Savazzi G
    J Vasc Interv Radiol; 2007 Feb; 18(2):177-85; quiz 185. PubMed ID: 17327549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contrast-induced nephropathy. Current concepts and propositions for Italian guidelines].
    Meschi M; Detrenis S; Savazzi G
    Recenti Prog Med; 2008 Mar; 99(3):155-62. PubMed ID: 18488528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of contrast-induced nephropathy in trauma patients.
    Hipp A; Desai S; Lopez C; Sinert R
    Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of contrast-induced nephropathy.
    McCullough PA; Sandberg KR
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S3-9. PubMed ID: 14668704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging.
    Josephson SA; Dillon WP; Smith WS
    Neurology; 2005 May; 64(10):1805-6. PubMed ID: 15911820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast media induced nephrotoxicity: problems in clinical practice.
    Stacul F; Cova M
    Radiol Med; 2003; 105(1-2):36-41. PubMed ID: 12700543
    [No Abstract]   [Full Text] [Related]  

  • 20. Contrast agent-induced nephropathy: a simple way to identify patients with preexisting renal insufficiency.
    Ashley JB; Millward SF
    AJR Am J Roentgenol; 2003 Aug; 181(2):451-4. PubMed ID: 12876025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.